Abstract:Purified‐BLIS produced by Streptomyces sp. is a novel candidate bacteriocin (class II bacteriocin) with low molecular mass (<2 kDa), broad‐spectrum antibacterial activity, low to moderate toxicity and quite good heat and pH stability, which characteristics show their potential to be developed and applied as bio‐preservative candidates in food processing. Summary Bacteriocins are antimicrobial peptides synthesised ribosomally by bacteria that can be used as natural preservatives. One potential bacteriocin‐producing bacteria that has yet to be widely studied is Streptomyces sp. Bioinformatics analysis has been conducted on the purified and identified bacteriocin‐like inhibitory substances (BLIS) produced by Streptomyces sp. The BLIS fraction, purified by reversed‐phase high‐performance liquid chromatography, showed significantly increased specific activities against E. coli, L. monocytogenes, S. aureus and S. typhimurium (1.2–189.4 folds). Identification of four purified BLIS fractions using HR‐LC‐ESI‐MS/MS revealed molecular mass from 1287.51 to 1812.85 Da with the sequences of TAEAEAAEGAEEAAP (fraction AS531), TQGGINANKTGSQGYG (fraction AS822), SGGYGGMGAGGIGGQRSGPQ (fraction AS857) and PGGAKGGFGGGGRPGGQGMPGG (fraction AS1121). These peptide sequences have a minimum of 2 hydrophobic amino acids, a net charge of −4 to +2, an isoelectric point of 2.68–11.71 and a hydrophobicity of 20.44–27.46 kcal mol−1. The results of molecular docking analysis between purified BLIS and the penicillin‐binding protein 3 (PBP‐3) receptor by methicillin‐resistant Staphylococcus aureus (MRSA) also showed that four fractions had low binding energy (−7.5 to −8.1 kcal mol−1) with 17–25 hydrogen bonds and distances <4 Å. Furthermore, in vitro characterisation revealed that the four purified‐BLIS have a low to moderate LC50 (68.81–200.35 μgmL−1) against A. salina and the ability to maintain 50% antibacterial activity against E. coli up to 100 °C for 30 min and in the pH range of 2.0–8.0, especially fractions AS531 and AS822. Based on the antibacterial spectrum, physicochemical characteristics and peptide sequence, BLIS produced by Streptomyces sp., is a novel bacteriocin with promising applications as a food preservative.

Bactofencin YH, a novel bacteriocin with high inhibitory activity against clinical Streptococcus species

Isolation and Partial Characterization of Antibiotics Produced by Paenibacillus Elgii B69.

Purification and Characterization of Plantaricin ZJ5, a New Bacteriocin Produced by Lactobacillus Plantarum ZJ5.

Purification and characterization of bacteriocin produced by a strain of Lacticaseibacillus rhamnosus ZFM216

Isolation and Characterization of A Bacteriocin Produced by an Isolated Bacillus Subtilis Lfb112 That Exhibits Antimicrobial Activity Against Domestic Animal Pathogens

Purification and characterization of a novel bacteriocin produced by Enterococcus faecalis CG-9 from human saliva

A Novel Bacteriocin Against Shigella flexneri From Lactiplantibacillus plantarum Isolated From Tilapia Intestine: Purification, Antibacterial Properties and Antibiofilm Activity

Purification and characterization of a novel bacteriocin from Lactobacillus paracasei ZFM54

Characterization and purification of acidocin 1B, a bacteriocin produced by Lactobacillus acidophilus GP1B

A Novel Bacteriocin From Lactobacillus Pentosus ZFM94 and Its Antibacterial Mode of Action

Battacin (octapeptin B5), A New Cyclic Lipopeptide Antibiotic from Paenibacillus Tianmuensis Active Against Multidrug-Resistant Gram-Negative Bacteria

Identification of A New Bacillus Licheniformis Strain Producing A Bacteriocin-Like Substance

A novel bacteriocin against multiple foodborne pathogens from Lacticaseibacillus rhamnosus isolated from juice ferments: ATF perfusion-based preparation of viable cells, characterization, antibacterial and antibiofilm activity

A comparison of mining methods to extract novel bacteriocins from Lactiplantibacillus plantarum NWAFU-BIO-BS29

Purification and characterization of a novel bacteriocin from Lactiplantibacillus plantarum Z057, and its antibacterial and antibiofilm activities against Vibrio parahaemolyticus

Lacticin LC14, a new bacteriocin produced by Lactococcus lactis BMG6.14: isolation, purification and partial characterization

Purification and antimicrobial mechanism of a novel bacteriocin produced by Lactobacillus rhamnosus 1.0320

A novel bacteriocin from Lactobacillus salivarius against Staphylococcus aureus: Isolation, purification, identification, antibacterial and antibiofilm activity

Discovery and Characterization of a Novel Bacteriocin That Strongly Inhibits Staphylococcus Aureus

Bacteriocin producing microbes with bactericidal activity against multidrug resistant pathogens

Bioinformatics analysis of purified and identified novel bacteriocin‐like inhibitory substances produced by Streptomyces sp.